News

AmerisourceBergen Corporation announced that it has signed a definitive agreement to acquire PharmaLex Holding GmbH, a leading provider of specialized services for the life sciences…
Read More...

Novo Nordisk and Microsoft have entered a new strategic collaboration to combine Microsoft’s computational services, cloud and artificial intelligence (AI) with Novo Nordisk’s drug…
Read More...

Novartis announced it is investing in next-generation biotherapeutics with the creation of a fully integrated, dedicated USD 300m scientific environment that will bolster its capacity…
Read More...

Autobahn Therapeutics, a biotechnology company focused on restoring hope for people affected by CNS disorders,  announced the closing of a $32.7 million financing to support the…
Read More...

Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Sotyktu (deucravacitinib), a first-in-class, oral, selective, allosteric tyrosine kinase 2…
Read More...

Gatehouse Bio, a pioneer in small RNA therapeutics, and AstraZeneca, a global, science-led biopharmaceutical company, are advancing their partnership, to create RNA therapeutics for the…
Read More...

Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases, announced that the U.S. Food and Drug…
Read More...

Pfizer Inc. announced that its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 or PF-06760805, received Breakthrough Therapy Designation from the U.S. Food and Drug…
Read More...

roofPilot and Citeline Connect, the most comprehensive solution for clinical trial engagement and recruitment, announced a strategic partnership to make clinical trials more accessible…
Read More...

Good Therapeutics, a privately held company, announced it has entered into a definitive merger agreement to be acquired by Roche. With this acquisition, Roche will gain rights to Good…
Read More...

Tetra Bio-Pharma Inc. announced they signed an agreement with Cellvera Global Holdings LLC ("Cellvera"), for the co-development of ARDS-003 as a combination product, with Qifenda 400MG…
Read More...

AceLink Therapeutics, Inc. (AceLink), an innovative biopharmaceutical company developing transformative therapies for genetic diseases, announced it has received Orphan Drug Designation…
Read More...

Advanco SA announced that it is partnering with Vantage Solutions to provide the first open, interoperable, and secure traceability solution for the Pharmaceutical Industry. advanco is…
Read More...

Evaxion Biotech A/S announced that the Company, in collaboration with UMass Chan Medical School, has received a grant from the U.S. National Institutes of Health (“NIH”) for the…
Read More...

Curavit Clinical Research, a virtual contract research organization (VCRO), has entered into a long-term partnership with ixlayer to provide easy access to clinical-grade diagnostic lab…
Read More...

NaNotics LLC, a biopharmaceutical company developing NaNots, novel subtractive nanoparticles that treat disease by capturing and clearing pathogenic molecules from blood, announced a…
Read More...

Kite, a Gilead Company announced that the European Commission (EC) has approved its CAR T-cell therapy Tecartus (brexucabtagene autoleucel) for the treatment of adult patients 26 years…
Read More...

Bertis, a proteomics-based precision medicine technology development company (CEOs Dong-young Noh, Seung-man Han), announced on the 5th that the research results of their search for…
Read More...

InnoCare Pharma announced that BTK inhibitor orelabrutinib has been granted priority review for the treatment of relapsed or refractory Marginal Zone Lymphoma (R/R MZL) by the Center…
Read More...

AstraZeneca’s Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in China to reduce the risk of sustained estimated glomerular filtration…
Read More...